Stability of antibody drug conjugate formulations evaluated using solid-state hydrogen-deuterium exchange mass

Eunbi Cho1, Brendan M Mayhugh2, Jayasree M Srinivasan2

  • 1Department of Industrial and Physical Pharmacy, Purdue University, Robert E. Heine Pharmacy Building, 575 W Stadium Ave, West Lafayette, IN 47907, United States.

Insights

Solid-state hydrogen-deuterium exchange with mass spectrometry (ssHDX-MS) can predict antibody drug conjugate (ADC) formulation stability. This method identified destabilizing excipients, aligning with stressed stability studies.

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Pharmaceutical Sciences

Background:

  • Antibody drug conjugates (ADCs) are crucial in targeted cancer therapy.
  • Current FDA-approved ADCs utilize lyophilized formulations to ensure stability during storage and transport.
  • Linker stability is critical for ADC efficacy and safety.

Purpose of the Study:

  • To evaluate solid-state hydrogen-deuterium exchange with mass spectrometry (ssHDX-MS) as a tool for analyzing ADC protein structure and matrix interactions.
  • To assess the impact of common excipients on ADC formulation stability.
  • To compare ssHDX-MS results with accelerated stability data.

Main Methods:

  • Solid-state hydrogen-deuterium exchange with mass spectrometry (ssHDX-MS) was employed.
  • Formulations with and without common excipients (mannitol, polysorbate 80) were analyzed.
  • ssHDX-MS data was compared with accelerated stability results from size-exclusion chromatography (SEC).
  • Fourier-transform infrared spectroscopy (FTIR) was used for comparative analysis.

Main Results:

  • ssHDX-MS successfully identified the destabilizing effects of mannitol and polysorbate 80 on the ADC formulation.
  • The results from ssHDX-MS showed strong agreement with accelerated stability studies.
  • Fourier-transform infrared spectroscopy (FTIR) provided inconclusive results regarding formulation stability.

Conclusions:

  • ssHDX-MS is a valuable tool for analyzing protein structure and matrix interactions in ADC formulations.
  • ssHDX-MS demonstrates potential for predicting the relative stability of different ADC formulations.
  • This technique can aid in the development of more stable and effective ADC drug products.